SureTrader
Home > Boards > US Listed > Medical - Drugs > RXI Pharmaceuticals Corp (RXII)

Company logo. images.investorshub.advfn.com/images/uploads/2012/5/17/rtkhgrxii.jpg

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
PoemStone Member Profile
 
Followed By 852
Posts 27,882
Boards Moderated 1
Alias Born 11/05/10
160x600 placeholder
RXi Pharmaceuticals to Present at Immuno-Oncology Frontiers World Conference "PR Newswire (US)" - 1/17/2018 7:05:00 AM
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth "PR Newswire (US)" - 1/16/2018 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/5/2018 5:22:39 PM
RXi Pharmaceuticals Announces Reverse Stock Split "PR Newswire (US)" - 1/5/2018 12:45:00 PM
RXi Pharmaceuticals to Present at the 10th Annual Biotech Showcase Conference "PR Newswire (US)" - 12/29/2017 7:05:00 AM
RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with RXI-109 for Dermal Scarring "PR Newswire (US)" - 12/18/2017 7:05:00 AM
Medigene Collaborates with RXi Pharmaceuticals to Further Sharpen its Therapeutic T cells "PR Newswire (US)" - 12/11/2017 7:05:00 AM
RXi Pharmaceuticals and the Center for Cancer Immune Therapy at Herlev Hospital Announce Research Collaboration "PR Newswire (US)" - 12/1/2017 7:05:00 AM
RXi Pharmaceuticals Announces Positive Results with RXI-231 in Consumer Testing Program "PR Newswire (US)" - 11/29/2017 7:05:00 AM
RXi Pharmaceuticals and Gustave Roussy Announce Research Collaboration "PR Newswire (US)" - 11/13/2017 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/8/2017 7:12:23 AM
RXi Pharmaceuticals Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights "PR Newswire (US)" - 11/8/2017 7:05:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/8/2017 7:03:50 AM
RXi Pharmaceuticals Announces Participation in Leading European Healthcare Forums and Conferences "PR Newswire (US)" - 11/7/2017 7:05:00 AM
RXi Pharmaceuticals to Webcast Third Quarter 2017 Financial Results on Wednesday, November 8, 2017 "PR Newswire (US)" - 11/1/2017 7:05:00 AM
RXi Pharmaceuticals to Present at the 2017 Annual BIO Investor Forum "PR Newswire (US)" - 10/11/2017 7:05:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/2/2017 3:46:00 PM
RXi Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference "PR Newswire (US)" - 9/19/2017 7:05:00 AM
RXi Pharmaceuticals to Present at BioPharm America's 10th Annual International Partnering Conference "PR Newswire (US)" - 9/18/2017 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/15/2017 4:32:24 PM
RXi Pharmaceuticals Announces the Departure of Dr. Alexey Eliseev as Chief Business Officer "PR Newswire (US)" - 9/15/2017 4:30:00 PM
BioAxone BioSciences Awarded NINDS SBIR Funding for the Development of Self-Delivering RNAi (sd-rxRNA®) for the Treatment of... "PR Newswire (US)" - 9/15/2017 7:05:00 AM
RXi Pharmaceuticals Announces Completion of Enrollment of Phase 2 Clinical Trial with Samcyprone for Cutaneous Warts "PR Newswire (US)" - 9/6/2017 7:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 8/31/2017 4:32:56 PM
RXi Pharmaceuticals Corporation Selected to Present at the 8th Annual Investing for Cures Forum "PR Newswire (US)" - 8/31/2017 7:05:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist